: Currently generating approximately ₹250 crore ($30M USD) in revenue, with a target of ₹1,000 crore ($120M USD) within three years. 2. Financial Health & Funding
The company has successfully secured significant capital to fuel its expansion. is zeno stock a good buy
: Zenotech Laboratories (ZENOTECH) is a public company in India, but it is a separate entity. Deep Paper: Analyzing Zeno Health for Investment 1. Business Model & Growth Trajectory : Currently generating approximately ₹250 crore ($30M USD)